<DOC>
	<DOCNO>NCT00779909</DOCNO>
	<brief_summary>The burden chronic gingivitis periodontitis US disproportionately high among Non-Hispanic Blacks compare Non-Hispanic Whites . Chronic gingivitis highly prevalent chronic inflammatory disease may progress periodontitis , major cause tooth loss , Data in-vitro animal study suggest anti-inflammatory effect vitamin D ; however , dose-range vitamin D may anti-inflammatory effect human uncertain . Recent clinical study indicate beneficial effect vitamin D several important outcome may occur wide range serum 25-hydroxyvitamin D ( 25-OHD ) concentration , possibly concentration would require vitamin D intakes range 2 10 ten times high current RDA vitamin D. Because dark skin pigmentation potent inhibitor vitamin D photosynthesis , Non-Hispanic Blacks much low 25-OHD serum level Non-Hispanic Whites . These difference vitamin D status may partially explain racial disparity prevalence chronic gingivitis periodontitis observe US . We hypothesize oral cholecalciferol supplementation reduce susceptibility gingivitis wide range serum 25-OHD concentration Non-Hispanic Whites Non-Hispanic Blacks . We propose conduct simple , single-center , randomize , double-blind , placebo-controlled parallel-group dose-ranging study . We compare placebo dos 500 IU , 2,500 IU 5,000 IU vitamin D3 per day . We compare severity gingival inflammation develop response 28-day period unlimited plaque growth ( experimental gingivitis ) dosage group . Furthermore , evaluate association achieve 25-OHD level gingival inflammation . The result study several important implication , dietary vitamin D supplementation may simple , safe inexpensive mean reduce racial/ethnic disparity gingivitis , well reduce overall burden oral disease population whole . The study elucidate dose-response relationship anti-inflammatory effect vitamin D , turn may lead revision current recommendation regard nutritional supplementation vitamin D order optimize prevention important medical condition disease reduce racial health disparity .</brief_summary>
	<brief_title>Dose-dependent Anti-inflammatory Effects Vitamin D Human Gingivitis Model</brief_title>
	<detailed_description />
	<mesh_term>Gingivitis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>inform write consent healthy subject age 1864 year old serum 25hydroxyvitamin D concentration &lt; 62.5 nmol/L ( &lt; 25 ng/mL ) increase risk infectious endocarditis require antibiotic prophylaxis prior periodontal probe woman postmenopausal pregnancy plan pregnancy within period trial Periodontitis ( attachment loss ≥4 mm probe depths≥5 mm least one interproximal site ) Any need immediate dental treatment ( eligible completion treatment ) history hypercalcemia , malabsorption syndrome , abnormal sensitivity vitamin D hypervitaminosis D &lt; 3 teeth bleed probe &lt; 20 teeth present &lt; 8 interproximal space ( i.e. , papilla ) upper jaw mean plaque index &gt; 3 Current smoke former smoking cessation &lt; 5 year ago regular use medication prevention treatment disease ( include Aspirin , NSAIDs , corticosteroid , NOT include contraceptive ) Diabetes mellitus hypercalcemia ( serum calcium &gt; ULN ) , hypocalcemia ( serum calcium &lt; ULN ) , hyperparathyroidism ( serum PTH concentration &gt; ULN ) , hypoparathyroidism ( serum PTH concentration &lt; LLN ) cardiac rhythm abnormality baseline ECG use tan beds/unwillingness abstain use tan bed study plan travel study period / unwillingness abstain travel South High Altitudes unwillingness abstain use supplement ( include vitamin/mineral herbal supplement ) study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>gingivitis</keyword>
	<keyword>periodontal disease</keyword>
	<keyword>inflammation</keyword>
</DOC>